The lecture, "Sickle Cell Disease: New Insights into Management" was presented during the GAFP's 2012 Annual Scientific Assembly.
Sickle cell disease (SCD), the most common genetic disease screened for in the newborn period, occurs in ?1 in 2400 newborns in the general population and 1 in 400 individuals of African descent in the United States. Despite the relative high prevalence and low pediatric mortality rate of SCD when compared with other genetic diseases or chronic diseases in pediatrics, few evidence-based guidelines have been developed to facilitate the transition from pediatrics to family medicine environment. This activity offers effective tools that can be used to facilitate the transition.
Because young adults with SCD are living longer, the importance of transitioning from a pediatric primary care provider to adult primary care physician has become a critical step in the health care management plan. We identify how the primary care physicians in tandem with the pediatric specialist can enhance transition interventions for children and adolescents with SCD.
At the completion of this session, the participant will be able to:
- Understand the progress in sickle cell disease over the last century
- Learn the impact of newborn screening on prognosis
- Understand the contribution of hydroxyurea
- Understand the challenges of adult life and transitioning into the adult care system
This activity is supported, in part, by an educational grant from Funding for activities was made possible by the Georgia Department of Public Health via the Maternal and Child Health Section/ U.S. Department of Health and Human Services/Health Resources and Services Administration.